Warby Parker
WRBY • NYSE
Warby Parker is a medical - instruments & supplies company in the healthcare sector trading on NYSE, led by CEO Neil Harris Blumenthal, with a market cap of $3.1B.
CEONeil Harris Blumenthal
Market Cap$3.1B
Medical - Instruments & Supplies
Healthcare
Employees3.5K
Websitewarbyparker.com
Country
United States of America
Next Earnings
Upcoming earnings announcement for Warby Parker
Date
Thursday, May 7, 2026 (in 2 months)
Timing
Before Market Open (6:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
$0.09
Revenue Estimate
$239.9M
Earnings History
Past 12 earnings reports for Warby Parker
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 26, 2026 | Q4 2025 | -$0.05Est: $0.04 | -225.0% | $212.0MEst: $212.7M | -0.3% |  10-K |
| Nov 6, 2025 | Q3 2025 | $0.05Est: $0.07 | -28.6% | $221.7MEst: $224.3M | -1.2% | 10-Q |
| Aug 7, 2025 | Q2 2025 | -$0.01Est: $0.06 | -116.7% | $214.5MEst: $213.0M | +0.7% | 10-Q |
| May 8, 2025 | Q1 2025 | $0.03Est: $0.12 | -75.0% | $223.8MEst: $225.5M | -0.7% | 10-Q |
| Feb 27, 2025 | Q4 2024 | -$0.06Est: $0.03 | -300.0% | $190.6MEst: $187.6M | +1.6% | 10-K |
| Nov 7, 2024 | Q3 2024 | -$0.03Est: $0.05 | -160.0% | $192.4MEst: $190.1M | +1.2% | 10-Q |
| Aug 8, 2024 | Q2 2024 | -$0.06Est: $0.05 | -220.0% | $188.2MEst: $187.0M | +0.7% | 10-Q |
| May 9, 2024 | Q1 2024 | -$0.02Est: $0.07 | -128.6% | $200.0MEst: $196.4M | +1.8% | 10-Q |
| Feb 28, 2024 | Q4 2023 | -$0.01Est: $0.01 | -200.0% | $161.9MEst: $160.8M | +0.6% | 10-K |
| Nov 8, 2023 | Q3 2023 | $0.01Est: $0.01 | 0.0% | $169.8MEst: $164.4M | +3.3% | — |
| Aug 9, 2023 | Q2 2023 | $0.04Est: $0.02 | +100.0% | $166.1MEst: $162.5M | +2.2% | 10-Q |
| May 9, 2023 | Q1 2023 | $0.06Est: $0.05 | +20.0% | $172.0MEst: $166.7M | +3.1% | — |